mupirocin

Product NDC: 52959-743
11-digit product format: 529590743
Labeler code: 52959
Product ID: 52959-743_09fcfeb2-8e52-4417-86b5-63688d9ede45
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Mupirocin
Dosage form: OINTMENT
Route: TOPICAL
Labeler: H.J. Harkins Company, Inc.
Application: ANDA065123
Marketing category: ANDA
Marketing start: 2009-10-30
Marketing end: 0000-00-00
Substance: MUPIROCIN
Active strength: 20 mg/g
Pharmacologic classes: RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	52959-743		I	Inactivated by FDA		2026-08-17
excluded package	package	52959-743	52959-743-22	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52959-743-22	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52959-743-22	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52959-743-22	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52959-743-22	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52959-743-22	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52959-743-22	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52959-743-22	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52959-743-22	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52959-743-22	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52959-743-22	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52959-743-22	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52959-743-22	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	52959-743-22	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	52959-743-22	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	52959-743-22	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	52959-743-22	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	52959-743-22	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	52959-743-22	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	52959-743-22	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	52959-743-22	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	52959-743-22	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	52959-743-22	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065123-001	MUPIROCIN	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065123-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065123-001	MUPIROCIN	2%	OINTMENT / TOPICAL	AB	RS	2003-11-07	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065123-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065123-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065123-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065123-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065123-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065123-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065123-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065123-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065123-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065123-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065123-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065123-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065123-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065123-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065123-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065123-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065123-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065123-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065123-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065123-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065123-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065123-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065123-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065123-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065123-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065123-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065123-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065123-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065123-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065123-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065123-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065123-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065123-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065123-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065123-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065123-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065123-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065123-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065123-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065123-001	AB	1	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f2f8c312-f164-6104-0de4-ec45484840e3	Product name	2	20260304
0c2e0212-b823-4ce8-611e-853ac2cac1b2	Product name	4	20230327
3db2f5c1-f78c-f062-515c-4827e36c2518	Product name	1	20140508
f74f326b-f453-01a0-e7e7-ce5ea9475503	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52959-743-22	2020-01-31	C162847	48780-1	9d75b9d0-97a5-f424-e053-dadaa90a57ce	MUPIROCIN OINTMENT USP, 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
52959-743-22	mupirocin	1 in 1 CARTON	OINTMENT	1		1
52959-743-22	mupirocin	22 g in 1 TUBE	OINTMENT	22		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52959-743-22	GM - Gram	52959-743	0fb79e39-2c6e-4b01-8930-2c4fbe27ddda	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MUPIROCIN	ACTIVE INGREDIENT	D0GX863OA5	MUPIROCIN OINTMENT [H.J. HARKINS COMPANY, INC.]	1
MUPIROCIN	ACTIVE MOIETY	D0GX863OA5	MUPIROCIN OINTMENT [H.J. HARKINS COMPANY, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	MUPIROCIN OINTMENT [H.J. HARKINS COMPANY, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52959-743	MUPIROCIN OINTMENT [H.J. HARKINS COMPANY, INC.]	1	Legacy NDC, 2 package rows	20111205_6a0b39c0-c207-4efc-ac2c-07506ad796df.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
mupirocin	MUPIROCIN	Preferred Pharmaceuticals Inc.	6c9cd7fc-b72e-406e-b9aa-0f1bc035b832	2026-07-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	HAWAII REPACK, INC.	7eaa296c-3f98-4f11-b4c1-62c2bc22a9a1	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	St. Mary's Medical Park Pharmacy	235c4f77-e751-a69f-e063-6394a90a1f96	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	REMEDYREPACK INC.	290b4e51-59b4-429a-987b-715ac817ef2c	2026-01-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	6cef3abf-9f17-459e-86b9-95896d9620b7	2025-10-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	7e7675fb-4bfa-46ac-ac1b-0918593d63ee	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	ATLANTIC BIOLOGICALS CORP.	da2f7d4e-82c6-4790-8eea-3a97e5b30734	2025-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
Mupirocin	MUPIROCIN OINTMENT	Kesin Pharma Corporation	b8e115ce-c8ff-4d08-b865-71dc4d0e51a1	2025-05-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	NuCare Pharmaceuticals,Inc.	831060e6-17ef-b0a0-e053-2991aa0aeb4f	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	A-S Medication Solutions	a6c22c25-0f02-4c06-bbc2-723a18ecdda8	2024-01-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Padagis Israel Pharmaceuticals Ltd	e9b61f01-3c67-42a4-a62b-10f1d1343190	2023-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Bryant Ranch Prepack	1cd4c71f-138b-47c2-8ce8-9ac32408dc56	2023-07-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Proficient Rx LP	97f8d67d-c422-4a26-9394-24a5ec9719d9	2022-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123
mupirocin	MUPIROCIN	Asclemed USA, Inc.	b2ff9c56-ca19-48ca-bd08-4b33edb13a08	2020-11-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065123 application number: ANDA065123

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D0GX863OA5	MUPIROCIN	12650-69-0	MUPIROCIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
106346	mupirocin 2 % Topical Ointment	PSN	6a0b39c0-c207-4efc-ac2c-07506ad796df	1
106346	mupirocin 0.02 MG/MG Topical Ointment	SCD	6a0b39c0-c207-4efc-ac2c-07506ad796df	1
106346	mupirocin 2 % Topical Ointment	SY	6a0b39c0-c207-4efc-ac2c-07506ad796df	1
106346	mupirocin 20 MG per GM Topical Ointment	SY	6a0b39c0-c207-4efc-ac2c-07506ad796df	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
52959-743-22	52959074322	1 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
MUPIROCIN OINTMENT USP, 2%	H.J. Harkins Company, Inc. \| Perrigo New York Inc \| Perrigo Israel Pharmaceuticals LTD \| L Perrigo Company	2011-11-02	HUMAN PRESCRIPTION DRUG LABEL	1